Does a simple asthma ‘step-up’ regime based on the Asthma Control Test (ACT) score improve asthma outcomes? A pilot study.

Not Applicable

Completed

• Conditions: Asthma; Respiratory - Asthma

• Registration Number: ACTRN12612000966897
• Lead Sponsor: GlaxoSmithKline

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-07
• Study Completion: 2014-06-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 93

Inclusion Criteria

Doctor diagnosis of asthma
Aged 16-55
ACT score of less than or equal to 19 out of 25
Prescription of a short acting bronchodilator, or an inhaled corticosteroid (ICS) plus short acting bronchodilator

Exclusion Criteria

Treatment with long acting beta agonist (LABA)
A diagnosis of COPD, bronchiectasis or pulmonary fibrosis
Any other safety concern at the Investigator’s discretion
Inability to understand the study requirements and/or give informed consent to participate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in ACT score from baseline[End of study (6 months)]

Secondary Outcome Measures

Name	Time	Method
Proportion of patients with severe asthma exacerbations. Assessed by asking the participant[End of study (6 months)];Number of severe asthma exacerbations. Assessed by asking the participant[End of study (6 months)]